Sign In
Buy EW
$86.00
-1.66 (-1.89%)
At Close: Jun 03, 2026
Compared to Estimates, Edwards Lifesciences (EW) Q4 Earnings: A Look at Key Metrics
07:00pm, Tuesday, 10'th Feb 2026
The headline numbers for Edwards Lifesciences (EW) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall S
Edwards Lifesciences forecasts 2026 profit above estimates on heart devices strength
04:51pm, Tuesday, 10'th Feb 2026
Edwards Lifesciences on Tuesday forecast 2026 profit above estimates, betting on robust demand for its artificial heart valves and other medical devices, sending its shares up 3% in after-hours tradin
Edwards Lifesciences Reports Fourth Quarter Results
04:15pm, Tuesday, 10'th Feb 2026
IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter and full-year ended Dec. 31, 2025. Highlights and Outlook Q4 sales grew 13.3% to $1.57
The TAVR Pioneer Bets Everything on One Market as Its Competitor Spreads Risk
08:15am, Friday, 06'th Feb 2026
Edwards Lifesciences (NYSE: EW) and Boston Scientific (NYSE: BSX) both reported strong quarters, but the results reveal fundamentally different strategies in the heart device market.
Ahead of Edwards Lifesciences (EW) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics
10:16am, Thursday, 05'th Feb 2026
Evaluate the expected performance of Edwards Lifesciences (EW) for the quarter ended December 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its
Atlantic Union Bankshares Corp Purchases 11,384 Shares of Edwards Lifesciences Corporation $EW
04:24am, Thursday, 05'th Feb 2026
Atlantic Union Bankshares Corp increased its holdings in shares of Edwards Lifesciences Corporation (NYSE: EW) by 2,240.9% during the third quarter, according to the company in its most recent 13F fil
Edwards Lifesciences' Q4 Earnings on Deck: Here's What to Expect
11:25am, Wednesday, 04'th Feb 2026
EW gears up for Q4 earnings as investors watch TAVR momentum, fast-growing TMTT sales and steady surgical heart demand.
Telos Capital Management Inc. Purchases 9,670 Shares of Edwards Lifesciences Corporation $EW
04:54am, Wednesday, 04'th Feb 2026
Telos Capital Management Inc. raised its position in shares of Edwards Lifesciences Corporation (NYSE: EW) by 15.5% during the third quarter, according to its most recent disclosure with the Securitie
Edwards Lifesciences to Host Earnings Conference Call on February 10, 2026
07:05am, Tuesday, 03'rd Feb 2026
IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended December 31, 2025 after the market closes on Tuesday, February 10, and wi
Edwards Lifesciences to Present at the TD Cowen 46th Annual Health Care Conference
07:05am, Monday, 02'nd Feb 2026
IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate in the TD Cowen 46th Annual Health Care Conference on Monday, Mar. 2, 2026. Scott Ullem
Atle Fund Management AB Purchases 8,299 Shares of Edwards Lifesciences Corporation $EW
04:49am, Sunday, 01'st Feb 2026
Atle Fund Management AB increased its position in shares of Edwards Lifesciences Corporation (NYSE: EW) by 14.5% in the third quarter, according to the company in its most recent disclosure with the S
Beyond Biotech—3 Healthcare Stocks for Growth-Minded Investors
11:44am, Sunday, 25'th Jan 2026
Healthcare stocks rallied in 2025, breaking a two-year slump as investors chased steadier rates, better valuations, and improving earnings. The problem: mid-single-digit gains still lagged tech, leavi
Edwards Lifesciences Corporation (NYSE:EW) Given Consensus Recommendation of “Moderate Buy” by Analysts
02:26am, Monday, 19'th Jan 2026
Edwards Lifesciences Corporation (NYSE: EW - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the twenty-nine ratings firms that are currently covering the firm, Mar
Bank Hapoalim BM Sells 11,250 Shares of Edwards Lifesciences Corporation $EW
03:48am, Sunday, 18'th Jan 2026
Bank Hapoalim BM trimmed its holdings in Edwards Lifesciences Corporation (NYSE: EW) by 37.0% in the undefined quarter, according to the company in its most recent filing with the Securities and Excha
Wedgewood Partners: Q4 2025 Top Performers And Detractors
06:10am, Thursday, 15'th Jan 2026
Alphabet continued to make significant contributions to performance during the quarter. Taiwan Semiconductor Manufacturing also contributed to performance during the quarter. Old Dominion Freight Line
